Seroatlas · Human Serome Atlas

CLMN

Calmin

Also known as: CLMN_HUMAN, FLJ12383, KIAA0500, KIAA1188

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q96JQ2
Gene
CLMN
Ensembl
ENSG00000165959
Chromosome
14
Canonical length
1002 aa
Protein class
Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Nuclear bodies,Cytosol

OverviewNCBI Gene

Predicted to enable actin filament binding activity. Predicted to be involved in negative regulation of cell population proliferation. Predicted to act upstream of or within neuron projection development. Predicted to be located in membrane. Predicted to be part of meiotic nuclear membrane microtubule tethering complex. Predicted to be active in cytoplasm and nuclear outer membrane. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

1002 residues, UniProt reviewed canonical sequence.

>Q96JQ2|CLMN
     1  MAAHEWDWFQ REELIGQISD IRVQNLQVER ENVQKRTFTR WINLHLEKCN PPLEVKDLFV
    61  DIQDGKILMA LLEVLSGRNL LHEYKSSSHR IFRLNNIAKA LKFLEDSNVK LVSIDAAEIA
   121  DGNPSLVLGL IWNIILFFQI KELTGNLSRN SPSSSLSPGS GGTDSDSSFP PTPTAERSVA
   181  ISVKDQRKAI KALLAWVQRK TRKYGVAVQD FAGSWRSGLA FLAVIKAIDP SLVDMKQALE
   241  NSTRENLEKA FSIAQDALHI PRLLEPEDIM VDTPDEQSIM TYVAQFLERF PELEAEDIFD
   301  SDKEVPIEST FVRIKETPSE QESKVFVLTE NGERTYTVNH ETSHPPPSKV FVCDKPESMK
   361  EFRLDGVSSH ALSDSSTEFM HQIIDQVLQG GPGKTSDISE PSPESSILSS RKENGRSNSL
   421  PIKKTVHFEA DTYKDPFCSK NLSLCFEGSP RVAKESLRQD GHVLAVEVAE EKEQKQESSK
   481  IPESSSDKVA GDIFLVEGTN NNSQSSSCNG ALESTARHDE ESHSLSPPGE NTVMADSFQI
   541  KVNLMTVEAL EEGDYFEAIP LKASKFNSDL IDFASTSQAF NKVPSPHETK PDEDAEAFEN
   601  HAEKLGKRSI KSAHKKKDSP EPQVKMDKHE PHQDSGEEAE GCPSAPEETP VDKKPEVHEK
   661  AKRKSTRPHY EEEGEDDDLQ GVGEELSSSP PSSCVSLETL GSHSEEGLDF KPSPPLSKVS
   721  VIPHDLFYFP HYEVPLAAVL EAYVEDPEDL KNEEMDLEEP EGYMPDLDSR EEEADGSQSS
   781  SSSSVPGESL PSASDQVLYL SRGGVGTTPA SEPAPLAPHE DHQQRETKEN DPMDSHQSQE
   841  SPNLENIANP LEENVTKESI SSKKKEKRKH VDHVESSLFV APGSVQSSDD LEEDSSDYSI
   901  PSRTSHSDSS IYLRRHTHRS SESDHFSYVQ LRNAADLDDR RNRILTRKAN SSGEAMSLGS
   961  HSPQSDSLTQ LVQQPDMMYF ILFLWLLVYC LLLFPQLDVS RL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CLMN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.57
Highest tissue expression
31 nTPM

Expression across tissuesHPA

Tissue

  • testis: 31 nTPM
  • pancreas: 17 nTPM
  • kidney: 14 nTPM
  • liver: 13 nTPM
  • rectum: 12 nTPM
  • colon: 11 nTPM

Single-cell type

  • oligodendrocytes: 641 nCPM
  • distal convoluted tubule cells: 540 nCPM
  • late spermatids: 516 nCPM
  • vascular smooth muscle cells: 493 nCPM
  • pericytes: 409 nCPM
  • renal connecting tubule cells: 406 nCPM

Immune cell

  • basophil: 7.3 nTPM
  • classical monocyte: 6.9 nTPM
  • neutrophil: 5.7 nTPM
  • memory B-cell: 3 nTPM
  • intermediate monocyte: 2.4 nTPM
  • plasmacytoid DC: 2.4 nTPM

Brain region

  • white matter: 160 nTPM
  • thalamus: 114 nTPM
  • basal ganglia: 104 nTPM
  • cerebral cortex: 102 nTPM
  • midbrain: 80 nTPM
  • pons: 73 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.7
gnomAD pLI
0
gnomAD missense Z
0.18
DepMap mean gene effect
0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CLMN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CLMN as an antibody target. Whether an autoantibody or antibody against CLMN could matter depends on whether native CLMN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CLMN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CLMN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CLMN. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...